Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.008
Buy
RSI(14)
53.979
Neutral
STOCH(KDJ)(9,3,3)
69.889
Neutral
ATR(14)
0.999
Low Volatility
CCI(14)
77.503
Neutral
Williams %R
24.943
Buy
TRIX(12,20)
0.060
Sell
StochRSI(14)
100.000
Buy
Search
AGMB.NB
AGMBAdd to Watchlist
12.870USD
+0.115+0.90%
Close 07-31 16:00（ET）Quotes delayed by 15 min
633.82MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.90%
5 Days
+2.88%
1 Month
+1.74%
6 Months
0.00%
Year to Date
0.00%
1 Year
0.00%
Key Figures
12.760Open
13.000High
54.09KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.11%Turnover Ratio
12.755Prev. Close
12.255Low
552.73KTurnover
--P/E Static
4.10P/B
0.00%Div Yield TTM
--ROA
17.45352wk High
1.15Volume Ratio
--Net Profit
48.74MShares
-1.0927EPS TTM
--Beta
--ROE
9.00052wk Low
5.84%Amplitude
--Gross Margin
633.82MMarket Cap
-0.94Reward/Risk
6.01%Risk Rate
AGMB.NB News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
6
analysts
Buy
Current Rating
33.200
Target Price
+157.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
AGMB.NB
AGMB
6
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
12.615
Buy
MA10
12.378
Buy
MA20
12.538
Buy
MA50
11.930
Buy
MA100
11.748
Buy
MA200
12.354
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AGMB.NB Info
Agomab Therapeutics NV is a Belgium-based company. The Company is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The Company also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.
Ticker SymbolAGMB
CompanyAGMB.NB
CEOKnotnerus (Tim)
Websitehttps://agomab.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
53028.700
+650.700 (+1.24%)
28291.100
+130.200 (+0.46%)
7529.800
+54.700 (+0.73%)
14605.000
-144.000 (-0.98%)
62575.000
-277.000 (-0.44%)
6418.600
+53.200 (+0.84%)
78.260
-7.674 (-8.93%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4061.260
+19.830 (+0.49%)
FAQs
What is the current price of AGMB.NB (AGMB)?
The current price of AGMB.NB (AGMB) is 12.87.
What is the symbol of AGMB.NB?
The ticker symbol of AGMB.NB is AGMB.
What is the 52-week high of AGMB.NB?
The 52-week high of AGMB.NB is 17.45.
What is the 52-week low of AGMB.NB?
The 52-week low of AGMB.NB is 9.00.
What is the market capitalization of AGMB.NB?
The market capitalization of AGMB.NB is 633.82M.
Is AGMB.NB (AGMB) currently rated as Buy, Hold, or Sell?
According to analysts, AGMB.NB (AGMB) has an overall rating of Buy, with a price target of 33.20.
What is the Earnings Per Share (EPS TTM) of AGMB.NB (AGMB)?
The Earnings Per Share (EPS TTM) of AGMB.NB (AGMB) is -1.51.